Compare LYFT Inc (LYFT) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? LYFT Inc trades at $16.16 (market cap $6.11B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.1× LYFT Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while LYFT Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold LYFT Inc for 47 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| LYFT | RPRX | |
|---|---|---|
Market Cap | $6.11B | $25.27B |
Volume | 13,504,560 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $24.57 | $63.96 |
52-Week Low | $12.65 | $35.44 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $5.57B | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $15.60, down 1.02% with a bullish technical signal despite recent earnings misses. The company shows strong fundamental improvement with revenue growing from $4.1B in 2022 to $6.3B in 2025 and achieving profitability with $2.84B net income. Recent developments include European expansion and a $272.5M legal settlement. Valuation metrics appear attractive with P/E of 2.27 and P/S of 0.93, though EV/EBITDA remains elevated at 33.28.
Lyft presents a mixed outlook with strong cash flow growth and expanding operations balanced against competitive pressures and regulatory risks. The stock trades below analyst consensus target of $18.07, offering potential upside, but faces headwinds from driver classification lawsuits and market saturation concerns. Execution on European expansion and sustained profitability will be key catalysts for further appreciation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
